Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge - Wikidata - awgldk - TriplyDB

Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge

Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge

http://www.wikidata.org/entity/Q28168954

about

Preparation and Characterization of a Polyclonal Antibody against Brominated Protein Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge Biomarkers in asthma: a real hope to better manage asthma.Evaluation of Serum 3-Bromotyrosine Concentrations in Dogs with Steroid-Responsive Diarrhea and Food-Responsive Diarrhea Stability of 3-bromotyrosine in serum and serum 3-bromotyrosine concentrations in dogs with gastrointestinal diseases.New Insights in Oxidant Biology in Asthma.Oxidative stress in airway diseases.Understanding and applying tyrosine biochemical diversity.Canine eosinophilic gastrointestinal disorders.Reduced clot retraction rate and altered platelet energy production in patients with asthma.Quantification of Modified Tyrosines in Healthy and Diabetic Human Urine using Liquid Chromatography/Tandem Mass Spectrometry.Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism.Development and analytic validation of an electron ionization gas chromatography/mass spectrometry (EI-GC/MS) method for the measurement of 3-bromotyrosine in canine serum.Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria.[Adaptive desensitization for acetylsalicylic acid hypersensitivity: A success story?].

P2860

Q24654224-62373061-DB04-4C1E-8DD7-EF8AE958AD90 Q28210320-4DE6A294-1B0D-41FD-8F85-13C99DAADFDC Q30417360-BBD8AB83-DE80-4616-AE38-7BEEB5FD537D Q33900097-F4EA30D9-06C3-4594-9FA7-EAEE0FCF69B3 Q34987829-4E23AE82-C321-4FE1-90B6-5B60B8A5D873 Q37241572-06329AD5-20EA-4C0F-A818-3D6882FE1685 Q38169242-32822002-0947-405E-A65A-1A2CAEBD3EC9 Q38195522-FBFE4568-DCA5-4FC1-892D-64E20EC9AD37 Q38210803-2FE75076-1AD3-4B54-B2D4-D504A64AE41F Q39795377-B924C28C-4C80-42B4-8BD6-94E12D3216A6 Q42068992-56AA7DE5-A20E-4E2A-8EE3-CAC2A0C38DCA Q46725621-65ECDFC1-E353-439F-929B-33C822218D8D Q48156084-3B7D0814-C7F1-4BCE-A29E-3A8425D3AE6D Q48827149-757DE465-9B55-4680-9EBD-66D10A9CFA1B Q53341936-231B748B-013C-43AE-AF4E-D4C7EA64B839

P2860

Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge

http://www.wikidata.org/entity/Q28168954

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@ast

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@en

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@nl

type

label

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@ast

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@en

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@nl

prefLabel

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@ast

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@en

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@nl

P1433

Q28168954-C5A341E6-43E2-40B7-A12A-D034E9DB4090

P1476

Q28168954-66DD46C4-58B7-4754-B2DE-9F9AC4C8C729

P2093

Q28168954-00DDC17B-D5AD-4096-B4CA-DF8594206A9B

Q28168954-21F7D571-FA8F-4BDA-8F97-2E34F285B2D2

Q28168954-4DBF5DEC-2621-40C6-9818-88490C1DB10C

Q28168954-5530B603-E1C1-4571-A72C-20164041DE46

Q28168954-95B72EA9-D677-46F6-B0BD-5BC73856E257

Q28168954-D56C9C34-84E0-410E-93AB-73132B613263

P2860

Q28168954-16A2AAC1-6F85-4A3D-8E44-847A0ED66098

Q28168954-1D863275-E228-41B8-AF1C-38D31FE4E880

Q28168954-285EC282-8AAB-49E2-8AFC-EA865F7A61C0

Q28168954-297B77DB-0D03-4FFF-ADC3-2EFC638CB63C

Q28168954-3900FD6C-AC84-4142-B233-5CD7214A77B5

Q28168954-7A73CF0B-406A-46F0-9C8E-F803E1B2D447

Q28168954-84F2C3C8-16D8-4D40-AEC6-8E9317B52DB4

Q28168954-9AA3D236-9D1F-4700-89CA-F1EE3E64C453

Q28168954-9AFA8448-D467-4278-B5BB-FC89BA329305

Q28168954-C316B37C-F7B0-4556-83E0-55BBE8BB1180

P304

Q28168954-09D6AFC3-413A-4A81-8A3A-B067794E202A

P31

Q28168954-65660721-6FBC-4C65-AF8D-84FB8F331EE0

P356

Q28168954-4B620B6C-6AB5-4258-9547-619861D966F8

P407

Q28168954-BB3994F6-6313-4CD7-A455-D50B85C5B9D8

P433

Q28168954-3DDF3426-338C-4403-9F6C-F57B4B72799D

P478

Q28168954-C3B74BE6-D081-436F-9AC0-A2E70F147947

P577

Q28168954-B2738920-CFAB-490E-83F3-C3DD7C4C05A9

P698

Q28168954-26067E48-2DFD-4415-AF4E-0B4B6DEF1638

P921

Q28168954-78CE64FD-DA31-4E88-9B3C-C8118EC4D6CE

Q28168954-FDEF3788-77EC-400A-AD68-13ED7433F9D6

P356

J.1365-2222.2004.01968.X

P1433

Clinical & Experimental Allergy

P1476

Urinary 3-bromotyrosine and 3- ...... intravenous aspirin challenge

@en

P2093

A Higashi

http://www.w3.org/2001/XMLSchema#string

H Mita

http://www.w3.org/2001/XMLSchema#string

K Akiyama

http://www.w3.org/2001/XMLSchema#string

M Taniguchi

http://www.w3.org/2001/XMLSchema#string

N Higashi

http://www.w3.org/2001/XMLSchema#string

Y Kawagishi

http://www.w3.org/2001/XMLSchema#string

P2860

A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma

Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils

Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts.

Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy.

Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species.

3-Chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: association with adverse respiratory outcome.

Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice.

Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tande

A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species.

P304

931-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2222.2004.01968.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15196282

http://www.w3.org/2001/XMLSchema#string

P921